Treatment options for chronic prostatitis due to vancomycin-resistant Enterococcus faecium

Eur J Clin Microbiol Infect Dis. 1998 Nov;17(11):798-800. doi: 10.1007/s100960050190.

Abstract

Prostatitis due to vancomycin-resistant enterococci has not been previously described. Reported here is a case of chronic prostatitis due to Enterococcus faecium, resistant to vancomycin, ampicillin, ciprofloxacin and doxycycline, in a 42-year-old liver transplant recipient. Treatment with a combination of rifampin and nitrofurantoin for 6 weeks resulted in long-lasting cure. Other antimicrobial agents active in vitro against vancomycin-resistant enterococci, such as quinupristin/ dalfopristin and chloramphenicol, are unlikely to achieve sufficient prostatic tissue levels to be successfully utilized for treatment of this condition.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents, Urinary / therapeutic use
  • Chronic Disease
  • Drug Resistance, Microbial
  • Drug Resistance, Multiple
  • Drug Therapy, Combination
  • Enterococcus faecium / drug effects*
  • Enterococcus faecium / isolation & purification
  • Gram-Positive Bacterial Infections / drug therapy*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Liver Transplantation / adverse effects
  • Male
  • Nitrofurantoin / therapeutic use*
  • Prostatitis / drug therapy*
  • Prostatitis / microbiology
  • Rifampin / therapeutic use*
  • Urine / microbiology
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents, Urinary
  • Vancomycin
  • Nitrofurantoin
  • Rifampin